相关实验视频
Updated: May 8, 2025

09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
24.7K
以外体驱动的纳米免疫疗法:彻底改变了结直肠癌的治疗方法
Masoud Lahouty1, Manouchehr Fadaee2,3,4, Dariush Shanehbandi4
1Department of Microbiology and Virology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Molecular biology reports
|December 26, 2024
概括
以外体驱动的纳米免疫疗法为传统结肠直肠癌 (CRC) 治疗提供了精确且不太有毒的替代方案. 这种创新方法利用外体作为天然纳米载体,用于增强药物输送和免疫调节.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 免疫治疗是一种免疫疗法.
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症相关死亡的主要原因.
- 传统疗法 (化疗,辐射,手术) 面临的局限性包括毒性和耐药性.
- 新的治疗策略对于改善CRC治疗结果至关重要.
研究的目的:
- 评估外体驱动的纳米免疫疗法作为结直肠癌的新型治疗方法.
- 为了比较基于外体的疗法与传统治疗方式的疗效.
- 突出外体在精确的药物输送和CRC的免疫调节中的潜力.
主要方法:
- 利用外体作为治疗剂的天然纳米载体.
- 利用外体的特性进行有针对性的输送和细胞间通信.
- 将基于外体的治疗疗法的有效性与传统治疗方法进行比较.
主要成果:
- 以外体驱动的纳米免疫疗法证明了治疗剂的精确输送.
- 与传统方法相比,这种方法显示出最大限度地降低系统毒性的潜力.
- 外体提供诸如生物相容性和跨越生物障碍的能力等优势.
结论:
- 以外体驱动的纳米免疫疗法为结直肠癌提供了一个有希望的,有针对性的治疗策略.
- 需要进一步的研究来规范外体细胞的生产和优化临床应用.
- 克服当前的挑战可以释放出基于外体的疗法的全部潜力,以改善患者的治疗结果.
更多相关视频
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.3K
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.0K
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397